Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences - 30 Year Stock Price History | USNA

Historical daily share price chart and data for USANA Health Sciences since 1995 adjusted for splits and dividends. The latest closing stock price for USANA Health Sciences as of June 06, 2025 is 29.38.
  • The all-time high USANA Health Sciences stock closing price was 136.25 on July 25, 2018.
  • The USANA Health Sciences 52-week high stock price is 48.85, which is 66.3% above the current share price.
  • The USANA Health Sciences 52-week low stock price is 23.10, which is 21.4% below the current share price.
  • The average USANA Health Sciences stock price for the last 52 weeks is 35.56.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
USANA Health Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 29.9393 36.3900 36.3900 23.4300 29.3800 -18.14%
2024 43.2890 54.4500 54.4500 33.3800 35.8900 -33.04%
2023 59.0943 54.4600 67.9200 44.4400 53.6000 0.75%
2022 71.1160 102.9400 102.9400 48.6600 53.2000 -47.43%
2021 96.8984 77.9500 106.4500 77.9500 101.2000 31.26%
2020 76.4390 77.9000 91.2000 45.7800 77.1000 -1.85%
2019 80.8571 116.5500 118.9700 58.9200 78.5500 -33.28%
2018 106.8860 74.9500 136.2500 70.7500 117.7300 58.99%
2017 61.8283 62.2000 75.6000 54.2500 74.0500 21.00%
2016 62.6045 63.6050 74.1250 47.4100 61.2000 -4.19%
2015 62.7007 51.1400 88.0600 48.9650 63.8750 24.52%
2014 39.3646 38.4700 59.0900 28.8100 51.2950 35.74%
2013 32.5806 16.4400 45.7050 16.4400 37.7900 129.52%
2012 20.2209 15.7650 24.6250 15.4600 16.4650 8.43%
2011 15.9897 21.8300 21.8300 11.8000 15.1850 -30.10%
2010 18.7135 16.2250 22.5350 12.3200 21.7250 36.21%
2009 14.2776 16.6800 18.4950 9.2950 15.9500 -6.83%
2008 15.9444 18.0500 24.7400 9.3150 17.1200 -7.66%
2007 22.2569 26.2300 30.8000 14.7400 18.5400 -28.22%
2006 21.1419 18.9150 26.2200 17.9550 25.8300 34.67%
2005 21.9370 16.9550 26.5400 16.5250 19.1800 12.16%
2004 14.7882 14.8950 18.2500 11.6650 17.1000 11.76%
2003 9.6598 2.9700 19.2000 2.9700 15.3000 407.88%
2002 1.3439 0.3625 3.0125 0.2900 3.0125 895.87%
2001 0.4609 0.3281 0.7188 0.3025 0.3025 -19.33%
2000 0.9648 1.1875 1.8750 0.3203 0.3750 -70.00%
1999 2.1249 2.5000 4.3125 1.0313 1.2500 -50.62%
1998 3.4141 2.2656 5.6875 2.1875 2.5313 11.73%
1997 2.0536 2.2656 2.6719 1.1563 2.2656 0.69%
1996 2.4237 1.3125 3.8750 1.0938 2.2500 58.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.547B $0.855B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.949B 32.62
Zoetis (ZTS) United States $75.757B 28.27
Takeda Pharmaceutical (TAK) Japan $47.602B 9.47
Daiichi Sankyo, - (DSNKY) Japan $45.824B 23.49
BeOne Medicines - (ONC) Cayman Islands $28.015B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.544B 0.00
Merck (MKKGY) Germany $16.989B 12.45
Summit Therapeutics (SMMT) United States $15.291B 0.00
United Therapeutics (UTHR) United States $14.697B 13.00
Shionogi (SGIOY) Japan $14.292B 0.00
Neurocrine Biosciences (NBIX) United States $12.409B 42.51
IPSEN (IPSEY) France $10.165B 0.00
Orion OYJ (ORINY) Finland $10.083B 27.27
Corcept Therapeutics (CORT) United States $7.381B 60.00
Stevanato Group S.p.A (STVN) Italy $7.189B 43.96
Madrigal Pharmaceuticals (MDGL) United States $6.178B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.064B 0.00
Ionis Pharmaceuticals (IONS) United States $5.617B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.913B 14.94
Soleno Therapeutics (SLNO) United States $3.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.156B 11.06
Crinetics Pharmaceuticals (CRNX) United States $3.091B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 19.46
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.388B 12.91
BioCryst Pharmaceuticals (BCRX) United States $2.310B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.261B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
Indivior (INDV) United States $1.940B 8.23
Dyne Therapeutics (DYN) United States $1.671B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.592B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
Ocular Therapeutix (OCUL) United States $1.437B 0.00
ARS Pharmaceuticals (SPRY) United States $1.423B 0.00
Guardian Pharmacy Services (GRDN) United States $1.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.107B 22.14
Harrow (HROW) United States $1.086B 0.00
Akebia Therapeutics (AKBA) United States $1.043B 0.00
Enliven Therapeutics (ELVN) United States $1.018B 0.00
Collegium Pharmaceutical (COLL) United States $0.970B 5.23
Avadel Pharmaceuticals (AVDL) Ireland $0.940B 0.00
Ardelyx (ARDX) United States $0.880B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.714B 0.00
Xencor (XNCR) United States $0.687B 0.00
Liminatus Pharma (LIMN) United States $0.630B 0.00
Elite Pharmaceuticals (ELTP) United States $0.620B 0.00
AleAnna (ANNA) United States $0.617B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.569B 0.00
Theravance Biopharma (TBPH) United States $0.563B 0.00
Verve Therapeutics (VERV) United States $0.552B 0.00
Bioventus (BVS) United States $0.550B 13.94
Zevra Therapeutics (ZVRA) United States $0.506B 0.00
Tourmaline Bio (TRML) United States $0.495B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Oruka Therapeutics (ORKA) United States $0.471B 0.00
Altimmune (ALT) United States $0.456B 0.00
Siga Technologies (SIGA) United States $0.431B 9.00
Savara (SVRA) United States $0.422B 0.00
Organogenesis (ORGO) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.384B 10.38
Aquestive Therapeutics (AQST) United States $0.354B 0.00
Heron Therapeutics (HRTX) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.298B 0.00
ProKidney (PROK) United States $0.286B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.59
Esperion Therapeutics (ESPR) United States $0.242B 0.00
MediWound (MDWD) Israel $0.233B 0.00
Nanobiotix S.A (NBTX) France $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Lyell Immunopharma (LYEL) United States $0.189B 0.00
OmniAb (OABI) United States $0.183B 0.00
Journey Medical (DERM) United States $0.172B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Avita Medical (RCEL) United States $0.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.137B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Wellgistics Health (WGRX) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.098B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.095B 15.66
VAXART, INC (VXRT) United States $0.093B 0.00
Inotiv (NOTV) United States $0.092B 0.00
Unicycive Therapeutics (UNCY) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.67
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.033B 0.00
Lyra Therapeutics (LYRA) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Tempest Therapeutics (TPST) United States $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.028B 0.00
Jupiter Neurosciences (JUNS) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
GlycoMimetics (GLYC) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00